Anti-TNF-α therapies in systemic lupus erythematosus

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Yang, Xiao ^a   Zhu, Lang Jing ^a   Yu, Xue Qing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

AUTOIMMUNITY; CROHN DISEASE; HUMAN; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; CLINICAL TRIAL; DRUG ANTAGONISM; METABOLISM; PATHOLOGY;

ANAS;

ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955409102     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/465898     Document Type: Review

References (73)

1. Manson J. J., Isenberg D. A., The pathogenesis of systemic lupus erythematosus The Netherlands Journal of Medicine 2003 61 11 343 346
2. Locksley R. M., Killeen N., Lenardo M. J., The TNF and TNF receptor superfamilies: integrating mammalian biology Cell 2001 104 4 487 501
3. Wajant H., Pfizenmaier K., Scheurich P., Tumor necrosis factor signaling Cell Death and Differentiation 2003 10 1 45 65
4. Aringerl M., Feierl E., Steiner G., Stummvoll G. H., Hfler E., Steiner C. W., Radda I., Smolen J. S., Graninger W. B., Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death Lupus 2002 11 2 102 108
5. Kollias G., Kontoyiannis D., Douni E., Kassiotis G., The role of TNF/TNFR in organ-specific and systemic autoimmunity: implications for the design of optimized 'anti-TNF' therapies Current Directions in Autoimmunity 2002 5 30 50
6. Aringer M., Graninger W. B., Steiner G., Smolen J. S., Safety and efficacy of tumor necrosis factor blockade in systemic lupus erythematosus: an open-label study Arthritis and Rheumatism 2004 50 10 3161 3169
7. Baud V., Karin M., Signal transduction by tumor necrosis factor and its relatives Trends in Cell Biology 2001 11 9 372 377
8. Xanthoulea S., Pasparakis M., Kousteni S., Brakebusch C., Wallach D., Bauer J., Lassmann H., Kollias G., Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases Journal of Experimental Medicine 2004 200 3 367 376
9. MacEwan D. J., TNF ligands and receptors - A matter of life and death British Journal of Pharmacology 2002 135 4 855 875
10. Hsu H., Xiong J., Goeddel D. V., The TNF receptor 1-associated protein TRADD signals cell death and NF- B activation Cell 1995 81 4 495 504
11. Hsu H., Shu H.-B., Pan M.-G., Goeddel D. V., TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways Cell 1996 84 2 299 308
12. Hsu H., Huang J., Shu H.-B., Baichwal V., Goeddel D. V., TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex Immunity 1996 4 4 387 396
13. Chinnalyan A. M., O'Rourke K., Tewari M., Dixit V. M., FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis Cell 1995 81 4 505 512
14. Wiegmann K., Schutze S., Kampen E., Himmler A., Machleidt T., Kronke M., Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades Journal of Biological Chemistry 1992 267 25 17997 18001
15. Rothe M., Pan M.-G., Henzel W. J., Ayres T. M., Goeddel D. V., The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins Cell 1995 83 7 1243 1252
16. Rothe M., Sarma V., Dixit V. M., Goeddel D. V., TRAF2-Mediated activation of NF- B by TNF receptor 2 and CD40 Science 1995 269 5229 1424 1427
17. Liu Z.-G., Molecular mechanism of TNF signaling and beyond Cell Research 2005 15 1 24 27
18. McDevitt H., Munson S., Ettinger R., Wu A., Multiple roles for tumor necrosis factor- and lymphotoxin alpha/beta in immunity and autoimmunity Arthritis Research 2002 4 supplement 3 S141 S152
19. Aringer M., Smolen J. S., Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus Arthritis Research and Therapy 2003 5 4 172 177
20. Kollias G., Kontoyiannis D., Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments Cytokine and Growth Factor Reviews 2002 13 4-5 315 321
21. Feldmann M., Brennan F. M., Maini R. N., Role of cytokines in rheumatoid arthritis Annual Review of Immunology 1996 14 397 440
22. Sicotte N. L., Voskuhl R. R., Onset of multiple sclerosis associated with anti-TNF therapy Neurology 2001 57 10 1885 1888
23. Sandborn W. J., Hanauer S. B., Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety Inflammatory Bowel Diseases 1999 5 2 119 133
24. Ramos-Casals M., Brito-Zern P., Muoz S., Soria N., Galiana D., Bertolaccini L., Cuadrado M.-J., Khamashta M. A., Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases Medicine 2007 86 4 242 251
25. Kontoyiannis D., Kollias G., Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor European Journal of Immunology 2000 30 7 2038 2047
26. Jacob C. O., McDevitt H. O., Tumour necrosis factor- in murine autoimmune 'lupus' nephritis Nature 1988 331 6154 356 358
27. Gordon C., Wofsy D., Effects of recombinant murine tumor necrosis factor- on immune function Journal of Immunology 1990 144 5 1753 1758
28. Brennan D. C., Yui M. A., Wuthrich R. P., Kelley V. E., Tumor necrosis factor and IL-1 in New Zealand black/white mice. Enhanced gene expression and acceleration of renal injury Journal of Immunology 1989 143 11 3470 3475
29. Ghatak S., Sainis K., Owen F. L., Datta S. K., T-cell-receptor -and I-A -chain genes of normal SWR mice are linked with the development of lupus nephritis in NZB x SWR crosses Proceedings of the National Academy of Sciences of the United States of America 1987 84 19 6850 6853
30. Morel L., Rudofsky U. H., Longmate J. A., Schiffenbauer J., Wakeland E. K., Polygenic control of susceptibility to murine systemic lupus erythematosus Immunity 1994 1 3 219 229
31. Fujimura T., Hirose S., Jiang Y., Kodera S., Ohmuro H., Zhang D., Hamano Y., Ishida H., Furukawa S., Shirai T., Dissection of the effects of tumor necrosis factor- and class II gene polymorphisms within the MHC on murine systemic lupus erythematosus (SLE) International Immunology 1998 10 10 1467 1472
32. Rahman Z. S. M., Tin S.-K., Buenaventura P.-N. L., Ho C.-H., Yap E. P. H., Yong R. Y. Y., Koh D.-R., A novel susceptibility locus on chromosome 2 in the (New Zealand Black New Zealand White) F 1 hybrid mouse model of systemic lupus erythematosus Journal of Immunology 2002 168 6 3042 3049
33. Le Hir M., Haas C., Marino M., Ryffel B., Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice Laboratory Investigation 1998 78 12 1625 1631
34. Ryffel B., Eugster H., Haas C., Le Hir M., Failure to induce anti-glomerular basement membrane glomerulonephritis in TNF / deficient mice International Journal of Experimental Pathology 1998 79 6 453 460
35. Hikahashi J., Takayanagi A., Hishikawa K., Takase O., Chikaraishi A., Hayashi M., Shimizu N., Saruta T., Overexpression of truncated I B potentiates TNF- -induced apoptosis in mesangial cells Kidney International 2000 57 3 959 968
36. Duffield J. S., Erwig L.-P., Wei X.-Q., Liew F. Y., Rees A. J., Savill J. S., Activated macrophages direct apoptosis and suppress mitosis of mesangial cells Journal of Immunology 2000 164 4 2110 2119
37. Segal R., Dayan M., Zinger H., Mozes E., Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNF monoclonal antibody and by pentoxiphylline Lupus 2001 10 1 23 31
38. Gergely P. Jr., Grossman C., Niland B., Puskas F., Neupane H., Allam F., Banki K., Phillips P. E., Perl A., Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus Arthritis and Rheumatism 2002 46 1 175 190
39. Emlen W., Niebur J., Kadera R., Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus Journal of Immunology 1994 152 7 3685 3692
40. Kovacs B., Vassilopoulos D., Vogelgesang S. A., Tsokos G. C., Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: role of decreased intracellular TNF-α Clinical Immunology and Immunopathology 1996 81 3 293 302
41. Studnicka-Benke A., Steiner G., Petera P., Smolen J. S., Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus British Journal of Rheumatology 1996 35 11 1067 1074
42. Gmez D., Correa P. A., Gmez L. M., Cadena J., Molina J. F., Anaya J.-M., Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor protective? Seminars in Arthritis and Rheumatism 2004 33 6 404 413
43. Zhu L.-J., Landolt-Marticorena C., Li Timothy, Altered expression of TNFα-signaling pathway proteins in systemic lupus erythematosus. The Journal of Rheumatology. In press
44. Jacob C. O., Fronek Z., Lewis G. D., Koo M., Hansen J. A., McDevitt H. O., Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor : relevance to genetic predisposition to systemic lupus erythematosus Proceedings of the National Academy of Sciences of the United States of America 1990 87 3 1233 1237
45. Jacob C. O., McDevitt H. O., Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis Nature 1988 331 6154 356 358
46. Zhu L., Yang X., Chen W., Li X., Ji Y., Mao H., Nie J., Yu X., Decreased expressions of the TNF-alpha signaling adapters in peripheral blood mononuclear cells (PBMCs) are correlated with disease activity in patients with systemic lupus erythematosus Clinical Rheumatology 2007 26 9 1481 1489
47. Maas K., Chan S., Parker J., Slater A., Moore J., Olsen N., Aune T. M., Cutting edge: molecular portrait of human autoimmune disease Journal of Immunology 2002 169 1 5 9
48. Rosen A., Casciola-Rosen L., Clearing the way to mechanisms of autoimmunity Nature Medicine 2001 7 6 664 665
49. Balomenos D., Martnez A. C., Cell-cycle regulation in immunity, tolerance and autoimmunity Immunology Today 2000 21 11 551 555
50. Jin O., Sun L.-Y., Zhou K.-X., Zhang X.-S., Feng X.-B., Mok M.-Y., Lau C.-S., Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus Clinical Rheumatology 2005 24 2 107 110
51. Devitt A., Pierce S., Oldreive C., Shingler W. H., Gregory C. D., CD14-dependent clearance of apoptotic cells by human macrophages: the role of phosphatidylserine Cell Death and Differentiation 2003 10 3 371 382
52. Gabler C., Kalden J. R., Lorenz H.-M., The putative role of apoptosis-modified histones for the induction of autoimmunity in systemic lupus erythematosus Biochemical Pharmacology 2003 66 8 1441 1446
53. Gordon C., Salmon M., Update on systemic lupus erythematosus: autoantibodies and apoptosis Clinical Medicine 2001 1 1 10 14
54. Boswell J. M., Yui M. A., Burt D. W., Kelley V. E., Increased tumor necrosis factor and IL-1β gene expression in the kidneys of mice with lupus nephritis Journal of Immunology 1988 141 9 3050 3054
55. Yokoyama H., Kreft B., Kelley V. R., Biphasic increase in circulating and renal TNF-α in MRL-lpr mice with differing regulatory mechanisms Kidney International 1995 47 1 122 130
56. Tsai C.-Y., Wu T.-H., Huang S.-F., Sun K.-H., Hsieh S.-C., Han S.-H., Yu H.-S., Yu C.-L., Abnormal splenic and thymic IL-4 and TNF-α expression in MRL-lpr/lpr mice Scandinavian Journal of Immunology 1995 41 2 157 163
57. Deguchi Y., Kishimoto S., Tumour necrosis factor/cachectin plays a key role in autoimmune pulmonary inflammation in lupus-prone mice Clinical and Experimental Immunology 1991 85 3 392 395
58. Edwards C. K. III, Zhou T., Zhang J., Baker T. J., De M., Long R. E., Borcherding D. R., Bowlin T. L., Bluethmann H., Mountz J. D., Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-α Journal of Immunology 1996 157 4 1758 1772
59. Brennan D. C., Yui M. A., Wuthrich R. P., Kelley V. E., Tumor necrosis factor and IL-1 in New Zealand black/white mice. Enhanced gene expression and acceleration of renal injury Journal of Immunology 1989 143 11 3470 3475
60. Nakamura T., Ebihara I., Fukui M., Osada S., Tomino Y., Masaki T., Goto K., Furuichi Y., Koide H., Renal expression of mRNAs for endothelin-1, endothelin-3 and endothelin receptors in NZB/I WF1 mice Renal Physiology and Biochemistry 1993 16 5 233 243
61. Takemura T., Yoshioka K., Murakami K., Akano N., Okada M., Aya N., Maki S., Cellular localization of inflammatory cytokines in human glomerulonephritis Virchows Archiv 1994 424 5 459 464
62. Herrera-Esparza R., Barbosa-Cisneros O., Villalobos-Hurtado R., Avalos-Daz E., Renal expression of IL-6 and TNF genes in lupus nephritis Lupus 1998 7 3 154 158 (Pubitemid 28190678)
63. Flanc R. S., Roberts M. A., Strippoli G. F., Chadban S. J., Kerr P. G., Atkins R. C., Treatment for lupus nephritis Cochrane Database of Systematic Reviews 2004 1
64. Aringer M., Smolen J. S., Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention Lupus 2004 13 5 344 347
65. Zhu L., Yang X., Ji Y., Chen W., Guan W., Zhou S. F., Yu X., Up-regulated renal expression of TNF- signalling adapter proteins in lupus glomerulonephritis Lupus 2009 18 2 116 127
66. Wu A. J., Hua H., Munson S. H., McDevitt H. O., Tumor necrosis factor- regulation of CD 4 + C 25 + T cell levels in NOD mice Proceedings of the National Academy of Sciences of the United States of America 2002 99 19 12287 12292
67. Malide D., Russo P., Bendayan M., Presence of tumor necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients Human Pathology 1995 26 5 558 564
68. Zhu L.-J., Yang X., Li X.-Y., Liu Q.-H., Tang X.-Q., Zhou S.-F., Kong Q.-Y., Axelsson J., Yu X.-Q., Suppression of tumor necrosis factor receptor associated factor (TRAF)-2 attenuates the proinflammatory and proliferative effect of aggregated IgG on rat renal mesangial cells Cytokine 2010 49 2 201 208
69. Feldmann M., Development of anti-TNF therapy for rheumatoid arthritis Nature Reviews Immunology 2002 2 5 364 371
70. Aringer M., Smolen J. S., Efficacy and safety of TNF-blocker therapy in systemic lupus erythematosus Expert Opinion on Drug Safety 2008 7 4 411 419
71. Uppal S. S., Hayat S. J., Raghupathy R., Efficacy and safety of infliximab in active SLE: a pilot study Lupus 2009 18 8 690 697
72. Aringer M., Houssiau F., Gordon C., Graninger W. B., Voll R. E., Rath E., Steiner G., Smolen J. S., Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients Rheumatology 2009 48 11 1451 1454
73. Soforo E., Baumgartner M., Francis L., Allam F., Phillips P. E., Perl A., Induction of systemic lupus erythematosus with tumor necrosis factor blockers Journal of Rheumatology 2010 37 1 204 205